Posted in | News | Sensors General

Melexis Announces Changes to Board of Directors and Management

Melexis, a global microelectronics engineering company, today announces the following upcoming changes in its board of directors and management. All changes will be effective as from 1 August 2021.

The Board has decided to nominate and appoint Mrs. Françoise Chombar, Melexis’ chief executive officer, as chairwoman of the Board from 1 August 2021 onwards. Mr. Roland Duchâtelet, current chairman of the Board, will remain a member of the Board.

Mr. Marc Biron will be appointed as the new chief executive officer of Melexis to replace Mrs. Chombar and will become in charge of the general management of the company. Subject to the approval of the shareholders during the Annual Shareholders’ Meeting in May, he will also join the Board as from 1 August 2021. Between now and 1 August, a transition period will take place where Mr. Biron and Mrs. Chombar will work side by side to ensure a smooth handover.

Mr. Biron joined Melexis in 1997 at the age of 27 and has built up extensive experience in the automotive industry. From 2009 to 2017 he was VP global development & quality and from 2018 onwards he has been general manager of the Sense & Drive business unit. Mr. Biron has been a member of the executive team since 2010.

Mr. Duchâtelet explains: “Since Melexis’ inception, more than 30 years ago, we have pursued a philosophy of moving to the backstage over the long run, strengthening the internal organization and enabling it to ensure adequate business continuity.”

Mrs. Chombar comments: “Going into my 18th year of tenure as CEO to Melexis and now that Melexis is back on its growth path, it is a good time to make this change. Albeit in a different role, I will continue to serve Melexis as my first priority. Marc is the best successor I could wish for and I will be by his side during and after the six-month transition period, in the capacity of chairwoman. He is well placed to guide us through the transition that the automotive industry, a key area for Melexis, is in today. In addition, he has started paving the way for the company to also apply its wealth of technological knowhow to carefully selected new markets.

I would like to explicitly thank Roland and the Board to have graciously elected me as their chairwoman from August 1st onwards. Roland has been and continues to be a superb mentor, and we are pleased that he will continue contributing to the works of the Board.”

Mr. Biron adds: “Melexis is an exceptional company with a steep growth path and I am delighted and feel truly privileged to be given the opportunity to guide this company into the next chapters of its exciting journey.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Melexis Microelectronic Systems. (2021, February 03). Melexis Announces Changes to Board of Directors and Management. AZoSensors. Retrieved on November 21, 2024 from https://www.azosensors.com/news.aspx?newsID=14332.

  • MLA

    Melexis Microelectronic Systems. "Melexis Announces Changes to Board of Directors and Management". AZoSensors. 21 November 2024. <https://www.azosensors.com/news.aspx?newsID=14332>.

  • Chicago

    Melexis Microelectronic Systems. "Melexis Announces Changes to Board of Directors and Management". AZoSensors. https://www.azosensors.com/news.aspx?newsID=14332. (accessed November 21, 2024).

  • Harvard

    Melexis Microelectronic Systems. 2021. Melexis Announces Changes to Board of Directors and Management. AZoSensors, viewed 21 November 2024, https://www.azosensors.com/news.aspx?newsID=14332.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.